Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Johnson & Johnson (JNJ)  
$152.28 0.09 (0.06%) as of 4:30 Wed 6/25


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 2,630,000,000
Market Cap: 400.50(B)
Last Volume: 7,153,586 Avg Vol: 8,187,416
52 Week Range: $142.06 - $167.7
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     DOW JONES COMPOSITE
    DOW JONES INDUSTRIAL AVERAGE     NYSE COMPOSITE
    S&P 100     S&P 500
    MAJOR MARKET

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  29
Guru Rank Value     : 17.2
Guru Occurances    : 6

 

            6 Months   1 Year   2 Year  
 
Company Profile   Johnson & Johnson is a holding company. Through its subsidiaries, Co. is engaged in the research and development, manufacture and sale of products in the health care field. Co. has three business segments: Consumer Health, which includes products focused on personal healthcare used in the skin health/beauty, over-the-counter medicines, baby care, oral care, women's health and wound care markets; Pharmaceutical, which is focused on six therapeutic areas: Immunology, Infectious Diseases, Neuroscience, Oncology, Cardiovascular and Metabolism and Pulmonary Hypertension; and Medical Devices, which includes products used in the Interventional Solutions, Orthopaedics, Surgery, and Vision fields.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 1,000 1,000
Total Buy Value $0 $0 $147,220 $147,220
Total People Bought 0 0 1 1
Total Buy Transactions 0 0 1 1
Total Shares Sold 0 20,417 26,052 129,038
Total Sell Value $0 $3,226,800 $4,156,913 $20,815,201
Total People Sold 0 3 3 7
Total Sell Transactions 0 3 4 8
End Date 2025-03-27 2024-12-24 2024-06-25 2023-06-26

   
Records found: 642
  Page 1 of 26  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Reed John C EVP, Innovative Medicine, R&D   •       –      –    2025-05-01 4 D $156.31 $1,719,723 D/D (11,002) 29,795     -
   Reed John C EVP, Innovative Medicine, R&D   •       –      –    2025-05-01 4 OE $0.00 $0 D/D 25,255 40,797     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2025-03-18 4 GA $0.00 $0 I/I 130,852 130,852     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2025-03-18 4 GD $0.00 $0 D/D 130,852 275,967     -
   Decker Robert J VP Corporate Controller   •       –      –    2025-02-25 4 S $165.88 $1,160,994 D/D (6,999) 21,001 8%     
   Decker Robert J VP Corporate Controller   •       –      –    2025-02-25 4 OE $101.87 $712,988 D/D 6,999 28,000     -
   Wolk Joseph J Exec VP, CFO   •       –      –    2025-02-18 4 D $156.15 $119,923 D/D (768) 5,345     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2025-02-18 4 D $156.15 $250,152 D/D (1,602) 395,923     -
   Mulholland Kristen EVP, Chief HR Officer   •       –      –    2025-02-18 4 D $156.15 $18,738 D/D (120) 12,975     -
   Swanson James D. EVP, CIO   •       –      –    2025-02-18 4 D $156.15 $22,017 D/D (141) 16,621     -
   Taubert Jennifer L EVP, WWC. Innovative Medicine   •       –      –    2025-02-18 4 D $156.15 $101,654 D/D (651) 170,459     -
   Broadhurst Vanessa EVP, Global Corp Affairs   •       –      –    2025-02-18 4 D $156.15 $24,672 D/D (158) 21,681     -
   Decker Robert J VP Corporate Controller   •       –      –    2025-02-18 4 D $156.15 $14,678 D/D (94) 20,022     -
   Reed John C EVP, Innovative Medicine, R&D   •       –      –    2025-02-18 4 D $156.15 $60,118 D/D (385) 15,542     -
   Wengel Kathryn E EVP, Chief TO and Risk Officer   •       –      –    2025-02-18 4 D $156.15 $31,230 D/D (200) 90,837     -
   Schmid Timothy EVP, WW Chair, MedTech   •       –      –    2025-02-18 4 S $156.15 $62,928 D/D (403) 15,098 2%     
   Forminard Elizabeth Executive VP, General Counsel   •       –      –    2025-02-18 4 D $156.15 $47,938 D/D (307) 10,014     -
   Wolk Joseph J Exec VP, CFO   •       –      –    2025-02-15 4 OE $0.00 $0 D/D 1,971 6,113     -
   Duato Joaquin CEO and Chairman of the Board   •       •      –    2025-02-15 4 OE $0.00 $0 D/D 3,682 397,525     -
   Mulholland Kristen EVP, Chief HR Officer   •       –      –    2025-02-15 4 OE $0.00 $0 D/D 419 13,095     -
   Swanson James D. EVP, CIO   •       –      –    2025-02-15 4 OE $0.00 $0 D/D 492 16,762     -
   Taubert Jennifer L EVP, WWC. Innovative Medicine   •       –      –    2025-02-15 4 OE $0.00 $0 D/D 1,594 171,110     -
   Broadhurst Vanessa EVP, Global Corp Affairs   •       –      –    2025-02-15 4 OE $0.00 $0 D/D 492 21,839     -
   Decker Robert J VP Corporate Controller   •       –      –    2025-02-15 4 OE $0.00 $0 D/D 339 20,116     -
   Reed John C EVP, Innovative Medicine, R&D   •       –      –    2025-02-15 4 OE $0.00 $0 D/D 1,350 15,927     -
  642 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 26
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2025 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us